Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: A randomised controlled trial with Lactobacillus GG

Gut

Volumn 51, Issue 3, 2002, Pages 405-409

  Prantera, C ^a   Scribano, M L ^a   Falasco, G ^a   Andreoli, A ^a   Luzi, C ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DICOFLOR 60; PLACEBO; PROBIOTIC AGENT;

ABSCESS; ACNE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLONY FORMING UNIT; CROHN DISEASE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; ENDOSCOPY; FEMALE; HEMATURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEITIS; INTESTINE FLORA; LACTOBACILLUS; MALE; METEORISM; NAUSEA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SCORING SYSTEM;

ADULT; AGED; COLONOSCOPY; CROHN DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTOBACILLUS; MALE; MIDDLE AGED; PROBIOTICS; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 0036716855     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.3.405     Document Type: Article

References (40)

1. Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease
2. Enteric microflora in IBD: Pathogens or commensals?
3. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease
4. Antibiotic use in Crohn's disease. Why and how?
5. Inflammatory bowel disease: Etiology and pathogenesis
6. An antibiotic regimen for the treatment of active Crohn's disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin
7. Use of antibiotics in the treatment of active Crohn's disease: Experience with metronidazole and ciprofloxacin
8. Postoperative recurrence of Crohn's disease: Pathophysiology and prevention
9. Probiotics and inflammatory bowel disease: Is there a scientific rationale?
10. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
11. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
12. Efficacy of Lactobacillus GG as a diarrheal preventative in travelers diarrhea
13. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
14. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
15. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
16. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?
17. Saccharomyces boulardii in maintenance treatment of Crohn's disease
18. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: A randomized controlled study vs mesalamine
19. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
20. Proposed classification of patient subgroups in Crohn's disease
21. Predictability of the postoperative course of Crohn's disease
22. Natural course of Crohn's disease after ileocolic resection: Endoscopically visualised ileal ulcers preceeding symptoms
23. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract
24. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG
25. Classification of inflammatory bowel disease
26. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
27. Crohn's disease: The case for bacteria
28. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
29. Early lesions of recurrent Crohn's disease caused by infusion of intestinal content in excluded ileum
30. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection
31. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
32. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Preliminary results
33. Colonization of the human gastrointestinal tract by probiotic bacteria
34. Oral administration of Lactobacillus GG (L.GG) induces an antiinflammatory, TH-2 mediated systemic immune response towards intestinal organisms
35. Frequency and spectrum of microorganisms isolated from biopsy specimens in chronic colitis
36. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease
37. National Cooperative Crohn's Disease Study: Factors determining recurrence of Crohn's disease after surgery
38. Risk factors for early postoperative recurrence of Crohn's disease
39. Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics
40. Lactobacillus plantarum is superior to Lactobacillus GG in preventing colitis in IL-10 deficient mice